OpenAlex
PricingAboutJobs
Log inGet started
Work

Alzheimer's and Aducanumab: Unjust Profits and False Hopes

HTML

Year: 2021
Type: article
Source: The Hastings Center Report
DOI: 10.1002/hast.1264
Author: Leonard M. Fleck
Language: English

Topic: Alzheimer's disease research and treatments
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Keywords: aducanumab, Alzheimer's disease, accelerated approval, FDA advisory committee, drug pricing, Medicare reimbursement, physician ethical obligations, false hope, amyloid-beta, pharmaceutical profits
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W3174400893
FWCI: 3.721
Cites: 4
Cited by: 54
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security